تخطي إلى التنقل الرئيسي
تخطي إلى البحث
تخطي إلى المحتوى الرئيسي
الصفحة الرئيسية
المساعدة والأسئلة الشائعة
English
עברית
العربية
الصفحة الرئيسية
الملفات الشخصية
الوحدات البحثية
نتاج البحث
الجوائز
أنشطة
البحث حسب الخبرة أو الاسم أو الانتماء
عرض الملف الشخصي الخاص بـ Scopus
גליה רהב
Prof.
Full Professor
,
Department of Medicine
https://orcid.org/0000-0003-4039-0958
1984 …
2025
نتاج الأبحاث سنويًا
معاينة
بصمة
الشبكة
نتاج البحث
(263)
ملفات شخصية مماثلة
(6)
بصمة
تأتي تسميات الموضوعات هذه من أعمال هذا الشخص. فهما يشكلان معًا بصمة فريدة.
فرز حسب
الوزن
أبجديًا
Keyphrases
Israel
100%
COVID-19
50%
BNT162b2 Vaccine
40%
Confidence Interval
30%
BNT162b2
26%
PCV7
25%
Hospitalized Patients
22%
Receptor-binding Domain
21%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
20%
Neutralizing Antibodies
20%
Serovars
19%
Medical Center
19%
Salmonella Enterica Serovar Typhimurium (S. Typhimurium)
18%
Invasive Pneumococcal Disease
18%
Bacteremia
18%
Virulence
17%
Isavuconazole
17%
Immunogenicity
16%
Antibody Response
15%
Staphylococcus Aureus
15%
Human Immunodeficiency Virus Type 1 (HIV-1)
15%
Streptococcus Pneumoniae
15%
Salmonella Enterica
15%
Third Dose
15%
Vaccine Dose
15%
Vaccination
14%
Clostridium Difficile Infection
14%
Humoral Response
14%
Adverse Events
14%
Non-typhoidal Salmonella
13%
Invasive Fungal Disease
13%
Salmonella Enterica Serovar Infantis
13%
SPI1
13%
IgG Antibody
13%
Pathogenicity
13%
Risk Factors
12%
Odds Ratio
12%
Israeli
12%
Jerusalem
12%
Exonuclease Activity
12%
Excision
11%
Voriconazole
11%
Healthcare Workers
11%
Pneumococcal Conjugate Vaccine
11%
Clinical Characteristics
11%
DNA Synthesis
11%
Vancomycin
11%
Motility
10%
Klebsiella Pneumoniae (K. pneumoniae)
10%
Pregnant Women
10%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
72%
Diseases
52%
Bloodstream Infection
33%
Coronavirinae
25%
SARS Coronavirus
22%
Adverse Event
21%
COVID-19 Vaccine
20%
Receptor
19%
Neutralizing Antibody
17%
Messenger RNA
16%
Isavuconazole
15%
Pneumococcal Infection
14%
Placebo
14%
Staphylococcus Aureus
12%
Carbapenem
11%
Mycosis
11%
Infectious Agent
10%
Immunogenicity
10%
Immunoglobulin G Antibody
10%
Malignant Neoplasm
10%
Salmonella
10%
Vancomycin
10%
Mortality Rate
9%
Voriconazole
9%
HIV
9%
Prevalence
9%
mRNA Vaccine
9%
All Cause Mortality
8%
Candidemia
8%
Methicillin-Resistant Staphylococcus Aureus
7%
Vancomycin Intermediate Staphylococcus Aureus
7%
Listeriosis
7%
Chronic Lymphatic Leukemia
7%
Pharmacokinetics
7%
Randomized Controlled Trial
7%
Meticillin
7%
Prospective Study
7%
Antibiotics
7%
Amphotericin B
6%
Monoclonal Antibody
6%
Cohort Study
6%
Clinical Trial
6%
Combination Therapy
6%
Klebsiella pneumoniae
6%
Candida
5%
Pseudomonas aeruginosa
5%
Immunocompromised Patient
5%
Comorbidity
5%
Enterobacteriaceae
5%
Pathogenicity
5%
Medicine and Dentistry
Infection
67%
COVID-19
40%
Diseases
33%
Bloodstream Infection
20%
Human Immunodeficiency Virus
17%
Receptor Binding
13%
COVID-19 Vaccine
12%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Serotype
11%
Neutralizing Antibody
11%
Pneumococcal Infection
10%
Placebo
10%
Messenger RNA
10%
Staphylococcus Aureus
10%
Listeriosis
10%
Salmonella
10%
Host Cell
9%
Adverse Event
9%
Neonatal Infant
9%
Carbapenem
9%
Antibiotic Therapy
8%
Mortality Rate
8%
Diagnosis
8%
Immunoglobulin G
8%
Pathogenicity Island
8%
Antibody Response
8%
Combination Therapy
8%
Antibiotics
8%
Odds Ratio
7%
Pathogen
7%
Salmonella Enterica Serovar Paratyphi A
7%
Clostridium Difficile Infection
7%
Bezlotoxumab
7%
Pneumococcus Vaccine
7%
Blood Culture
7%
Coronavirinae
7%
Randomized Controlled Trial
6%
Retrospective Cohort Study
6%
Clinical Syndrome
6%
Pneumococcal Pneumonia
6%
Streptococcus Pneumonia
6%
Cell Invasion
6%
Pathogenicity
6%
Cross Sectional Study
5%
Fluconazole
5%
Humoral Immunity
5%
Cohort Analysis
5%
Cohort Effect
5%
Immunocompromised Patient
5%
Restriction Fragment Length Polymorphism
5%